Strategic Blueprint, LLC Eli Lilly & CO Transaction History

Strategic Blueprint, LLC

$1.49 Billion
Q3 2024

A detailed history of Strategic Blueprint, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Blueprint, LLC holds 11,563 shares of LLY stock, worth $9.11 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

11,563

Previous 12,026 3.85%

Holding current value

$9.11 Million

Previous $10.9 Million 5.91%

% of portfolio

0.69%

Previous 0.79%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$772.14 - $960.02 $357,500 - $444,489	-463 Reduced 3.85%	11,563 $10.2 Million
Q2 2024 Jul 26, 2024	SELL	$724.87 - $909.04 $94,957 - $119,084	-131 Reduced 1.08%	12,026 $10.9 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $25,464 - $34,068	-43 Reduced 0.35%	12,157 $9.46 Million
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $46,741 - $55,102	89 Added 0.73%	12,200 $7.11 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $117,803 - $162,410	-271 Reduced 2.19%	12,111 $6.51 Million
Q2 2023 Oct 18, 2023	BUY	$350.74 - $468.98 $2.49 Million - $3.33 Million	7,103 Added 134.55%	12,382 $5.81 Million
Q1 2023 Apr 28, 2023	BUY	$310.63 - $364.82 $178,922 - $210,136	576 Added 12.25%	5,279 $1.81 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $168,170 - $195,952	-523 Reduced 10.01%	4,703 $0
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $15,713 - $17,907	53 Added 1.02%	5,226 $1.69 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $174,206 - $204,543	625 Added 13.74%	5,173 $1.68 Million
Q1 2022 Aug 12, 2022	BUY	$234.69 - $291.66 $56,325 - $69,998	240 Added 5.57%	4,548 $1.3 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $295,003 - $366,100	1,312 Added 43.79%	4,308 $1.19 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $29,029 - $35,725	131 Added 4.57%	2,996 $692,000
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $40,623 - $52,546	225 Added 8.52%	2,865 $657,000
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $40,258 - $52,116	-245 Reduced 8.49%	2,640 $493,000
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $37,442 - $49,544	287 Added 11.05%	2,885 $487,000
Q3 2020 Oct 27, 2020	BUY	$146.22 - $169.13 $79,689 - $92,175	545 Added 26.55%	2,598 $385,000
Q2 2020 Jul 20, 2020	BUY	$136.42 - $164.18 $280,070 - $337,061	2,053 New	2,053 $337,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.

Account

Strategic Blueprint, LLC Eli Lilly & CO Transaction History